Antibiotic resistance patterns and serotype distribution in Streptococcus pneumoniae from hospitalized pediatric patients with respiratory infections in Suzhou, China

Journal of Tropical Pediatrics

Volumn 56, Issue 3, 2009, Pages 204-205

  Chen, R ^a   Chen, Y ^b   Black, S ^c   Hao, C L ^d   Ding, Y F ^d   Zhang, T ^a   Zhao, G M ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF OTTAWA   (Canada)

^c Cincinnati Children's Hospital   (United States)

^d CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; OFLOXACIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CHINA; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; LETTER; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PNEUMOCOCCAL INFECTION; RESPIRATORY TRACT INFECTION; SEROTYPE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; CLASSIFICATION; CROSS-SECTIONAL STUDY; DRUG EFFECT; FEMALE; HOSPITALIZATION; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PRESCHOOL CHILD; SEROTYPING;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; CHINA; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALIZATION; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; RESPIRATORY TRACT INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 77954889692     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmp078     Document Type: Letter

References (6)

1. World Health Organization. Pneumococcal conjugated vaccine for childhood immunization. Wkly Epidemiol Rep 2007;12:93-104.
2. Clinical and Laboratory Standards Institute, Institute CaLS. Methods for Dilution Antimicrobial Susceptibility for Bacteria that Grow Aerobically, Approved Standard M100-S16, 2006.
3. Inoue M, Farrell DJ, Kaneko K, et al. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-5 (1999-2004). Microb Drug Resist 2008;14:109-17.
4. Jenkins SG, Brown SD, Farrell DJ. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4. Ann Clin Microbiol Antimicrob 2008;7:1.
5. Black S, France EK, Isaacman D, et al. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2007;26:771-7.
6. Cherian T. WHO expert consultation on serotype composition of pneumococcal conjugate vaccines for use in resource-poor developing countries, 26-27 October 2006, Geneva. Vaccine 2007;25:6557-64.